Cointime

NGM Biopharmaceuticals

company

About

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

  • 101 - 250

Highlights

Total Funding Amount
$105.99M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Series E
Last Funding Money Raised
$105.99M
Industries
Biopharma,Biotechnology,Genetics,Medical
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active

NGM Biopharmaceuticals is a privately-held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. The company's current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$105.99M
NGM Biopharmaceuticals has raised a total of $105.99M in funding over 2 rounds. Their latest funding was raised on Mar 25, 2015 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 25, 2015 Series E $105.99M 1 Merck — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
NGM Biopharmaceuticals has made 1 investments. Their most recent investment was on Mar 1, 2016, when Sweatcoin raised $600K.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 1, 2016 Sweatcoin
Angel $600K Apps —

Investors

Number of Lead Investors
Number of Investors
1
1
NGM Biopharmaceuticals is funded by 1 investors. Merck are the most recent investors.
Investor Name Lead Investor Funding Round
Merck Yes Series E
Cointime
头条
热点
RSS
公司